Novel Rx

The Annual Review of Best ACR 2020 abstracts featuring Drs. Cush and Kavanaugh filmed on the last day of Virtual ACR 2020 Nov. 9, 2020. Watch now!

Here are my highlights from day three, Sunday, of the ACR 2020 Convergence.  Guidelines for Treatment of Polyarticular JIA ACR/AF guidelines for the management of juvenile idiopathic arthritis…

Saturday was the day 2 with many posters and live sessions at the 2020 Virtual ACR/ARP meeting. Here are a few of my highlights from day two: Targeting Plasmacytoid Dendritic Cells in Lupus…

Pegloticase, a mammalian PEGylated recombinant uricase is approved for chronic refractory gout treatment. It decreases the serum uric acid and the signs and symptoms of gout. High titer anti-drug…

Combination therapy with biologic and conventional DMARDs can be highly effective at inducing remission in patients with rheumatoid arthritis. Once controlled under therapy, patients are often very…

Friday was the first full day of scientific sessions at the 2020 Virtual ACR/ARP meeting. Here are a few of my highlights from day one: Safety of Recombinant Zoster Vaccine (RZV) (Abstract 0452…

Like any other systemic rheumatic disease, treating psoriatic arthritis (PsA) remains a challenge. Axial involvement is common and like AS, can have profound effects on the functional capacity and…

Each pharmaceutical company has spent months and years preparing to present and highlight their featured clinical trials and abstracts at ACR 2020.  This is our selection of their best studies…

Here is the last of our QD Clinics in Podcast form, just before we start ACR2020 coverage. In this compilation from the past week we talk about - HIV and arthritis - Hyperuricemia in PsA - An odd…

The risk of serious infections (SIE) in RA patients given anti-TNF (TNFi) therapy is not static, instead it has been shown to be greatest in the first 6 months of use according to a recent report in…